ZA-37 150 mg (Venlafaxine Hydrochloride Extended Release 150 mg)
Pill with imprint ZA-37 150 mg is Orange & White, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended Release 150 mg. It is supplied by Zydus Pharmaceuticals USA Inc.
Venlafaxine is used in the treatment of autism; anxiety; generalized anxiety disorder; depression; major depressive disorder and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ZA-37 150 mg



Venlafaxine Hydrochloride Extended Release
- Imprint
- ZA-37 150 mg
- Strength
- 150 mg
- Color
- Orange & White
- Size
- 21.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Serotonin-norepinephrine reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals USA Inc.
- Inactive Ingredients
-
silicon dioxide,
cetostearyl alcohol,
gelatin,
hypromelloses,
microcrystalline cellulose,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
ferric oxide red,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
68382-0036 | Zydus Pharmaceuticals (USA) Inc. |
60429-0123 (Discontinued) | Golden State Medical Supply (repackager) |
More about venlafaxine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2,568)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: serotonin-norepinephrine reuptake inhibitors
Patient resources
- Drug Information
- Venlafaxine (Advanced Reading)
- Venlafaxine Extended-Release Tablets
- Venlafaxine Tablets
- Venlafaxine Extended-Release Capsules
- Other brands
- Effexor, Effexor XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.